ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 1 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $156,000 | -5.5% | 253,918 | +100.0% | 0.00% | – |
| Q3 2018 | $165,000 | -4.1% | 126,959 | -0.5% | 0.00% | – |
| Q2 2018 | $172,000 | -38.8% | 127,543 | -34.4% | 0.00% | – |
| Q1 2018 | $281,000 | -35.6% | 194,375 | +0.3% | 0.00% | – |
| Q4 2017 | $436,000 | -29.3% | 193,875 | +6.7% | 0.00% | – |
| Q3 2017 | $617,000 | +0.3% | 181,682 | +4.8% | 0.00% | – |
| Q2 2017 | $615,000 | +8.8% | 173,404 | +4.3% | 0.00% | – |
| Q1 2017 | $565,000 | -24.0% | 166,210 | +2.9% | 0.00% | – |
| Q4 2016 | $743,000 | +19.1% | 161,526 | +9.6% | 0.00% | – |
| Q3 2016 | $624,000 | +193.0% | 147,387 | +65.5% | 0.00% | – |
| Q2 2016 | $213,000 | -40.0% | 89,034 | +17.8% | 0.00% | – |
| Q1 2016 | $355,000 | +19.5% | 75,575 | 0.0% | 0.00% | – |
| Q4 2015 | $297,000 | +3.1% | 75,575 | +1.5% | 0.00% | – |
| Q3 2015 | $288,000 | – | 74,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $11,907,000 | 1.66% |
| Northeast Financial Consultants Inc | 732,265 | $1,647,000 | 0.55% |
| AJ WEALTH STRATEGIES, LLC | 29,624 | $67,000 | 0.02% |
| Family Management Corp | 10,424 | $23,000 | 0.02% |
| Virtu Financial LLC | 71,588 | $161,000 | 0.01% |
| Poehling Capital Management, INC. | 2,802 | $6,000 | 0.01% |
| Founders Capital Management | 2,000 | $5,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $333,000 | 0.00% |
| WEDBUSH SECURITIES INC | 11,000 | $25,000 | 0.00% |
| THRIVENT FINANCIAL FOR LUTHERANS | 298,303 | $671,000 | 0.00% |